Cargando…
Comment on Neeland et al. The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial. Diabetes Care 2020;43:3007–3015
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247504/ https://www.ncbi.nlm.nih.gov/pubmed/34016615 http://dx.doi.org/10.2337/dc21-0310 |
| _version_ | 1783716536873123840 |
|---|---|
| author | Brikman, Shay Dori, Guy |
| author_facet | Brikman, Shay Dori, Guy |
| author_sort | Brikman, Shay |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8247504 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82475042022-06-01 Comment on Neeland et al. The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial. Diabetes Care 2020;43:3007–3015 Brikman, Shay Dori, Guy Diabetes Care e-Letters: Comments and Responses American Diabetes Association 2021-06 2021-06-18 /pmc/articles/PMC8247504/ /pubmed/34016615 http://dx.doi.org/10.2337/dc21-0310 Text en © 2021 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license. |
| spellingShingle | e-Letters: Comments and Responses Brikman, Shay Dori, Guy Comment on Neeland et al. The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial. Diabetes Care 2020;43:3007–3015 |
| title | Comment on Neeland et al. The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial. Diabetes Care 2020;43:3007–3015 |
| title_full | Comment on Neeland et al. The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial. Diabetes Care 2020;43:3007–3015 |
| title_fullStr | Comment on Neeland et al. The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial. Diabetes Care 2020;43:3007–3015 |
| title_full_unstemmed | Comment on Neeland et al. The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial. Diabetes Care 2020;43:3007–3015 |
| title_short | Comment on Neeland et al. The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial. Diabetes Care 2020;43:3007–3015 |
| title_sort | comment on neeland et al. the impact of empagliflozin on obstructive sleep apnea and cardiovascular and renal outcomes: an exploratory analysis of the empa-reg outcome trial. diabetes care 2020;43:3007–3015 |
| topic | e-Letters: Comments and Responses |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247504/ https://www.ncbi.nlm.nih.gov/pubmed/34016615 http://dx.doi.org/10.2337/dc21-0310 |
| work_keys_str_mv | AT brikmanshay commentonneelandetaltheimpactofempagliflozinonobstructivesleepapneaandcardiovascularandrenaloutcomesanexploratoryanalysisoftheemparegoutcometrialdiabetescare20204330073015 AT doriguy commentonneelandetaltheimpactofempagliflozinonobstructivesleepapneaandcardiovascularandrenaloutcomesanexploratoryanalysisoftheemparegoutcometrialdiabetescare20204330073015 |